MAPT and Alzheimer disease: Together, our results demonstrate that high-confidence GeneEMBED candidates show significant enrichment in modifiers of tau and β-amyloid phenotypes in Drosophila models, are differentially expressed in AD brain tissue, and show abnormal neurological phenotypes when modulated in mouse models.